经尿道前列腺1470 nm激光汽化术治疗良性前列腺增生的临床疗效

doi:10.3969/j.issn.1671-7171.2023.07.007

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1179 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the efficacy of transurethral vaporization of the prostate with 1470 nm laser (1470 nm DiLVP) in the treatment of patients with benign prostatic hyperplasia (BPH). 【Methods】A total of 114 patients with BPH admitted to our hospital from February 2019 to February 2022 were selected and divided into group A (receiving 1470 nm DiLVP treatment) and group B (receiving TUPKP treatment) based on different surgical plans, with 57 patients in each group. Perioperative parameters, maximum urinary flow rate (Q_max) before and after operation, IPSS score, residual urine volume (RUV), serum prostate specific antigen (PSA) level, stress factors [cortisol (Cor), adrenaline (AD), Norepinephrine (NE)] level and the incidence of complications were compared between the two groups.【Results】The hospitalization time, bladder flushing time, catheter retention time, and surgical time in the Group A were shorter than those in the Group B, and the intraoperative blood loss was lower than that in the Group B (P<0.05). The IPSS score, RUV, and PSA levels of the two groups of patients at 1 and 3 months after surgery were lower than those before surgery, while Q_max was higher than that before surgery (P<0.05); The IPSS score, RUV, and PSA levels in the Group A were lower than those in the Group B at 1 and 3 months after surgery, while Q_max was higher in the Group B (P<0.05). The serum NE, Cor, and AD levels were higher in both groups at 12 hours and 24 hours after surgery than those before, while the group A was lower than the group B, with statistically significant differences (P<0.05). The incidence of postoperative complications in the Group A was 1.75% (1/57), lower than the Group B [15.79% (9/57)], with a statistically significant difference (P<0.05). 【Conclusion】The application of 1470 nm DiLVP in the treatment of BPH can optimize perioperative indicators, improve patient condition, improve urinary control function, reduce postoperative complications, and have a smaller impact on the body's traumatic stress response.

Key words： Prostatic Hyperplasia/SU Transurethral Resection of Prostate/MT Treatment Outcome

Received: 23 July 2022

PACS:

R697.32

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SU Bin-jie
	CHEN Gang

Cite this article:

SU Bin-jie,CHEN Gang. Clinical Efficacy of 1470 nm Laser Vaporization of the Prostate through Urethra in the Treatment of Benign Prostatic Hyperplasia[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(7): 984-986.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.07.007 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I7/984

[1] 肖洪廷,吴江,奉静.经尿道钬激光前列腺剜除术和经尿道前列腺等离子电切术治疗良性前列腺增生的临床比较研究[J].中国性科学,2020,29(1):34-37.
[2] 钱凡,樊彩斌.TUVP联合TURP对高龄前列腺增生患者的疗效及术后发生膀胱颈挛缩相关因素分析[J].广东医学,2019,40(11):1637-1639.
[3] 梁烽扬,黎锋,郑业辉,等.经尿道摩西钬激光前列腺剜除术治疗良性前列腺增生的临床研究[J].国际泌尿系统杂志,2020,40(3):485-488.
[4] 车鹏,魏鑫,曾雄峰,等.1470 nm激光汽化术与经尿道前列腺电切术比较治疗良性前列腺增生有效性和安全性的Meta分析[J].中国循证医学杂志,2019,19(5):565-570.
[5] 程树林,李雨根,周文浩,等.经尿道前列腺1470 nm激化术与经尿道前列腺电切术治疗良性前列腺增生的疗效比较[J].国际泌尿系统杂志,2019,39(3):491-494.
[6] 杨帆,张强,范海泉.后路经皮微创椎弓根螺钉内固定术对脊柱骨折患者创伤应激状态、疼痛及功能恢复的影响[J].川北医学院学报,2022,37(3):307-311.
[7] 那彦群.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2011:9-34.
[8] 张庆鑫,殷晓蒙,沈进,等.组织刨削器辅助下经尿道等离子体解剖性前列腺推剥术治疗良性前列腺增生临床效果的研究[J].国际外科学杂志,2021,48(12):824-828.
[9] 王成明,李普,张倩,等.经尿道前列腺钬激光剜除术治疗小体积前列腺增生的疗效和安全性分析[J].中华泌尿外科杂志,2021,42(11):839-843.
[10] 韩利平,于文建,李刚.经尿道2微米激光前列腺切除术治疗前列腺增生并后尿道狭窄疗效观察[J].实用医院临床杂志,2019,16(5):63-65.
[11] 孟庆利,江彬,侯旭,等.经尿道前列腺等离子双极电切术与经尿道前列腺电切术治疗良性前列腺增生的临床疗效比较[J].贵州医药,2019,43(1):62-64.
[12] 王竞,时少显,和学强,等.等离子电切与激光汽化治疗良性前列腺增生临床效果及对IPSS、QOL、Q_max、PVR的影响[J].河北医科大学学报,2019,40(2):169-173.
[13] 马丁,任瑞民,尚吉文,等.CYR61和VEGF-C表达水平与良性前列腺增生临床进展的相关性分析[J].临床泌尿外科杂志,2019,34(6):444-448.
[14] 罗雷,杨彦辉,李季,等.胸腔镜与开胸手术治疗创伤性血气胸及对应激因子、疼痛因子影响的对照研究[J].创伤外科杂志,2020,22(7):521-524.